Xi, Juemin
Chen, Junying
Xu, Miaoling
Yang, Hongying
Wen, Songjiao
Pan, Yue
Wang, Xiaodan
Ye, Chao
Qiu, Lijuan
Sun, Qiangming
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (2016-I2M-3-026)
National “Twelfth Five Year” “major new drug discovery” technology major projects (2012ZX09104-302)
National Natural Science Foundation of China (81171946)
Natural Science Foundation of Yunnan Province (2016FA029)
Jointly Supported Foundation of the National Project in Yunnan Province (2013GA018)
Article History
Received: 17 January 2018
Accepted: 16 April 2018
First Online: 25 April 2018
Ethics approval and consent to participate
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the Institutional Ethics Committee of Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.